Literature DB >> 27211276

Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach.

Rani H Singh1, Amy C Cunningham2, Shideh Mofidi3, Teresa D Douglas4, Dianne M Frazier5, Debra Geary Hook6, Laura Jeffers7, Helen McCune8, Kathryn D Moseley9, Beth Ogata10, Surekha Pendyal11, Jill Skrabal12, Patricia L Splett13, Adrya Stembridge14, Ann Wessel15, Frances Rohr16.   

Abstract

BACKGROUND: In 2014, recommendations for the nutrition management of phenylalanine hydroxylase deficiency were published as a companion to the concurrently published American College of Medical Genetics and Genomics guideline for the medical treatment of phenylketonuria (PKU). These were developed primarily from a summary of findings from the PKU scientific review conference sponsored by the National Institutes of Health and Agency for Healthcare Research & Quality along with additional systematic literature review. Since that time, the Genetic Metabolic Dietitians International and the Southeast Regional Newborn Screening and Genetics Collaborative have partnered to create a web-based technology platform for the update and development of nutrition management guidelines for inherited metabolic disorders.
OBJECTIVE: The purpose of this PKU guideline is to establish harmonization in treatment and monitoring, to guide the integration of nutrition therapy in the medical management of PKU, and to improve outcomes (nutritional, cognitive, and developmental) for individuals with PKU in all life stages while reducing associated medical, educational, and social costs.
METHODS: Six research questions critical to PKU nutrition management were formulated to support guideline development: Review, critical appraisal, and abstraction of peer-reviewed studies and unpublished practice literature, along with expert Delphi survey feedback, nominal group process, and external review from metabolic physicians and dietitians were utilized for development of recommendations relevant to each question. Recommendations address nutrient intake, including updated protein requirements, optimal blood phenylalanine concentrations, nutrition interventions, monitoring parameters specific to life stages, adjunct therapies, and pregnancy and lactation. Recommendations were graded using a rigorous system derived from the Academy of Nutrition and Dietetics. RESULTS AND
CONCLUSION: These guidelines, updated utilizing a thorough and systematic approach to literature analysis and national consensus process, are now easily accessible to the global community via the newly developed digital platform. For additional details on specific topics, readers are encouraged to review materials on the online portal: https://GMDI.org/.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Guidelines; Inherited metabolic disorders; PKU; Phenylalanine; Phenylketonuria; Recommendations

Mesh:

Substances:

Year:  2016        PMID: 27211276     DOI: 10.1016/j.ymgme.2016.04.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  24 in total

1.  The Validity of Bioelectrical Impedance Analysis to Measure Body Composition in Phenylketonuria.

Authors:  Maureen Evans; Kay Nguo; Avihu Boneh; Helen Truby
Journal:  JIMD Rep       Date:  2017-11-24

2.  Characterization of Phenyalanine Hydroxylase Gene Mutations in Chilean PKU Patients.

Authors:  V Hamilton; L Santa María; K Fuenzalida; P Morales; L R Desviat; M Ugarte; B Pérez; J F Cabello; V Cornejo
Journal:  JIMD Rep       Date:  2017-12-30

3.  Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates.

Authors:  Debra S Regier; Agata Bąk; Heather Bausell; Emer O'Reilly; Lex M Cowsert
Journal:  Mol Genet Metab Rep       Date:  2022-03-08

4.  Breastfeeding practices for infants with inherited metabolic disorders: A survey of registered dietitians in the United States and Canada.

Authors:  Allison Buckingham; Aileen Kenneson; Rani H Singh
Journal:  Mol Genet Metab Rep       Date:  2022-04-04

5.  Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods.

Authors:  Bridget M Stroup; Denise M Ney; Sangita G Murali; Frances Rohr; Sally T Gleason; Sandra C van Calcar; Harvey L Levy
Journal:  J Nutr Metab       Date:  2017-12-31

Review 6.  Systems biology of personalized nutrition.

Authors:  Ben van Ommen; Tim van den Broek; Iris de Hoogh; Marjan van Erk; Eugene van Someren; Tanja Rouhani-Rankouhi; Joshua C Anthony; Koen Hogenelst; Wilrike Pasman; André Boorsma; Suzan Wopereis
Journal:  Nutr Rev       Date:  2017-08-01       Impact factor: 7.110

7.  Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report.

Authors:  A Pinto; M F Almeida; A Cunha; C Carmona; S Rocha; A Guimas; R Ribeiro; C R Mota; E Martins; A MacDonald; J C Rocha
Journal:  Mol Genet Metab Rep       Date:  2017-10-18

8.  Amino Acid Plasma Profiles from a Prolonged-Release Protein Substitute for Phenylketonuria: A Randomized, Single-Dose, Four-Way Crossover Trial in Healthy Volunteers.

Authors:  Mika Scheinin; Anna Barassi; Jouni Junnila; Zsófia Lovró; Giorgio Reiner; Essi Sarkkinen; Anita MacDonald
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

9.  Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.

Authors:  Yetsa Osara; Kathryn Coakley; Aishwarya Devarajan; Rani H Singh
Journal:  Orphanet J Rare Dis       Date:  2017-07-19       Impact factor: 4.123

10.  First-year metabolic control guidelines and their impact on future metabolic control and neurocognitive functioning in children with PKU.

Authors:  Alicia de la Parra; María Ignacia García; Valerie Hamilton; Carolina Arias; Juan Francisco Cabello; Verónica Cornejo
Journal:  Mol Genet Metab Rep       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.